Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Report of Consensus Panel 5 from 12th International Workshop on Waldenström’s macroglobulinemia on management of patients with intolerance or resistance to covalent BTK inhibitors provides multiple attractive next options.”
Title: Report of Consensus Panel 5 from the 12th International Workshop on Waldenström’s Macroglobulinemia on the management of patients with intolerance or resistance to covalent BTK inhibitors
Authors: Jorge J Castillo, Francesco Autore, Neil L Berinstein, Andrew R Branagan, Meletios A Dimopoulos, Carlos Fernandez de Larrea, Simone Ferrero, Prashant Kapoor, Efstathios Kastritis, Jahanzaib Khwaja, Monique C Minnema, Lugui Qiu, John F Seymour, Josephine M I Vos, Christopher J Patterson, Christian Buske, Jeffrey V Matous, Steven P Treon, M Lia Palomba
You can read the Full Article in Seminars in Hematology.
More posts featuring Robert Orlowski.
